Norges Bank’s Juno Therapeutics, Inc. JUNO Stock Holding History

Norges Bank’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-640,352	Closed	-$29.3M	–	2192
2017 Q4	$29.3M	Buy	640,352 +93,848	+17%	+$4.68M	0.01%	1204
2017 Q3	$24.5M	Sell	546,504 -780,569	-59%	-$26.6M	0.01%	1306
2017 Q2	$39.7M	Sell	1,327,073 -251,769	-16%	-$6.21M	0.02%	906
2017 Q1	$35M	Buy	1,578,842 +836,501	+113%	+$17.9M	0.01%	953
2016 Q4	$14M	Buy	742,341 +85,059	+13%	+$2.08M	0.01%	1526
2016 Q3	$18.8M	Buy	657,282 +77,229	+13%	+$2.4M	0.01%	1280
2016 Q2	$22.3M	Buy	580,053 +60,228	+12%	+$2.5M	0.01%	1135
2016 Q1	$19.8M	Buy	519,825 +51,225	+11%	+$1.78M	0.01%	1161
2015 Q4	$20.6M	Buy	468,600 +211,679	+82%	+$10.5M	0.01%	1148
2015 Q3	$10.5M	Buy	+256,921	New	+$11.3M	0.01%	1518
2015 Q1	–	Sell	-15,000	Closed	-$783K	–	2340
2014 Q4	$783K	Buy	+15,000	New	+$671K	﹤0.01%	2217

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Norges Bank's JUNO Position: Q1 2018 in Review

Norges Bank sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 640,352 shares — an estimated $29.3M sold.

Norges Bank first reported a position in JUNO in Q4 2014 and held it in 11 quarters. The position peaked at $39.7M in Q2 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Norges Bank reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Norges Bank sold 640,352 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $29.3M.
Norges Bank first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 11 quarters.
Norges Bank's Juno Therapeutics, Inc. position peaked at $39.7M in Q2 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Norges Bank's 13F filing for Q1 2018, filed 9 May 2018.